News Conference News EuroPCR 2015 DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device Yael L. Maxwell May 20, 2015
News Conference News EuroPCR 2015 NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients Yael L. Maxwell May 19, 2015
News Daily News Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT May 14, 2015
News Daily News Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical L.A. McKeown May 06, 2015
News Daily News After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR Todd Neale April 10, 2015
News Conference News ACC 2015 ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted Todd Neale March 20, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Daily News TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes L.A. McKeown March 10, 2015
News Daily News Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis February 19, 2015
News Daily News Year in Review: Physicians Highlight the Most Important Interventional News of 2014 Todd Neale January 12, 2015
News Daily News Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes Todd Neale December 16, 2014
Presentation Cardiovascular Interventions 2014 Show Me The Data: Key Clinical Trials in 2014 Presenter: David P. Faxon October 23, 2014
News Daily News PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation October 10, 2014
Presentation TCT 2014 Keystone Deflector Device - Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials) Presenter: Alexandra J. Lansky September 15, 2014
Presentation TCT 2014 CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014